Streetbeat News

Earnings

COYA

GLYC

LIXT

TMDX

WGS

The article highlights significant intraday movements in healthcare stocks, with GlycoMimetics, Lixte Biotechnology, and GeneDx Holdings among the top gainers, while TransMedics Group and Coya Therapeutics are notable losers. The movements are influenced by recent earnings reports and market reactions.

Portfolio Pulse from Benzinga Insights

October 29, 2024 | 4:31 pm

EFSH

JBI

JBLU

MNTS

PGHL

SKK

ULCC

ZCAR

Several industrial stocks experienced significant intraday movements on Tuesday. Notable gainers included Zoomcar Holdings, Momentus, and SKK Holdings, while major losers were 1847 Holdings, Primega Group Holdings, and Janus Intl Gr, with the latter releasing its Q3 earnings.

Portfolio Pulse from Benzinga Insights

October 29, 2024 | 4:30 pm

BKYI

CDNS

CVLT

DQ

HLIT

XRX

Several information technology stocks experienced significant price movements during Tuesday's intraday session. Notable gainers included BIO-key Intl, Cemtrex, CommVault Systems, Canaan, Greenidge Generation, and Cadence Design Systems. On the losing side, Daqo New Energy, Harmonic, SMX, Xerox Holdings, Phunware, and JinkoSolar Holding Co saw declines, with some companies reporting earnings that influenced their stock prices.

Portfolio Pulse from Benzinga Insights

October 29, 2024 | 4:30 pm

MSCI

MSCI has announced that it expects to be toward the higher end of its expense guidance range for the fiscal year 2024. This information was disclosed during a conference call.

Portfolio Pulse from Benzinga Newsdesk

October 29, 2024 | 4:28 pm

CBZ

CBIZ shares are experiencing an upward trend after the company reported better-than-expected earnings per share (EPS) for the third quarter.

Portfolio Pulse from Benzinga Newsdesk

October 29, 2024 | 4:21 pm

RMBS

Rambus shares are experiencing an increase in trading activity following the release of their Q3 earnings report.

Portfolio Pulse from Benzinga Newsdesk

October 29, 2024 | 4:18 pm

ABBV

AbbVie Inc (NYSE:ABBV) is set to report its Q3 earnings with expected EPS of $2.92 and revenues of $14.28 billion. Ahead of this, AbbVie acquired Aliada Therapeutics for $1.4 billion to enhance its Alzheimer's research. The stock shows mixed technical signals, with a short-term bearish trend but potential for a bullish turn. Analysts see a 10.58% upside with a price target of $210.

Portfolio Pulse from Surbhi Jain

October 29, 2024 | 4:15 pm

INCY

Incyte Corporation reported mixed Q3 earnings with revenue beating expectations but EPS missing estimates. Jakafi and Opzelura showed strong growth, leading to increased guidance for 2024. Analysts see potential for continued growth despite competition.

Portfolio Pulse from Vandana Singh

October 29, 2024 | 4:07 pm

LLY

Eli Lilly is set to report its Q3 earnings with expectations of $1.45 EPS and $12.10 billion in revenue. The stock has risen significantly, prompting stock split rumors. Despite a bearish short-term technical outlook, analysts see a potential 25% upside.

Portfolio Pulse from Surbhi Jain

October 29, 2024 | 4:04 pm

SCI

Service Corp Intl (NYSE:SCI) is set to announce its quarterly earnings on October 30, 2024. Analysts expect an EPS of $0.77. Investors are keen on the earnings and guidance, as past performance has shown significant stock price reactions.

Portfolio Pulse from Benzinga Insights

October 29, 2024 | 4:02 pm